The CDC said 8% of the country lacked health insurance in 2025, and it may rise this year

The U.S. uninsured rate held steady at about 8% in 2025, but the number of uninsured still rose by roughly 800,000, including 300,000 children, as population growth offset a stable rate. Looking ahead, Medicaid changes could add 10 million uninsured over a decade, while ACA subsidy expiration is expected to leave about 5 million fewer people enrolled in marketplace plans in 2026. The data point to a healthier baseline than a decade ago, but policy changes under the Trump administration create clear coverage headwinds for insurers, Medicaid-linked programs, and exchange participation.

Analysis

The near-term market read-through is not a sudden shock to medical-loss ratios, but a slow-burn demand reallocation across the healthcare stack. Coverage erosion tends to hit the highest-margin part of the system first: elective utilization, managed care membership growth, and downstream prescription adherence, while shifting volume toward county hospitals, charity care, and lower-acuity retail settings. That is negative for insurers with heavier exchange/Medicaid exposure and for provider names that rely on commercially insured ambulatory traffic; it is relatively supportive for discount-oriented care models and for names with strong cash-pay or government reimbursement mix.

The second-order effect is budget pressure, not just utilization pressure. If state Medicaid rolls shrink and exchange enrollment softens, political friction rises around uncompensated care funding, which often shows up with a lag in hospital rate negotiations, supplemental payments, and local tax support. That makes the real earnings risk a 12-24 month issue: today’s insurance-rate data is a lagging indicator, but the earnings revisions will come through next-year enrollment, higher bad debt, and more conservative utilization assumptions rather than an immediate headline hit.

The contrarian point is that the headline uninsured rate may underestimate the market impact because the composition matters more than the level. A modest change in total uninsured can still produce a disproportionate deterioration in profit pools if the marginally uninsured are younger, lower-income, and higher utilizers of acute care and generic drugs. At the same time, if administration policy successfully steers healthier lives into lower-premium catastrophic plans, the adverse selection problem worsens for ACA-heavy risk pools even without a dramatic change in total uninsured counts.

Key Decisions for Investors

• Short managed-care names with elevated ACA/Medicaid exposure versus a basket of large-cap diversified insurers over the next 6-12 months; best expression is a pair trade long UNH / short CNC or MOH, looking for multiple expansion in the diversified name as membership mix deteriorates elsewhere.
• Build a tactical short in hospital names with high charity-care sensitivity and weak balance sheets, such as HCA/THC-style exposure via puts on smaller-cap peers, targeting 3-6 months; risk/reward improves if state supplemental funding discussions stall into budget season.
• Long cash-pay and discount-care beneficiaries such as CVS or WBA only selectively if the market over-discounts enrollment loss; prefer call spreads 6-9 months out because volume can offset some coverage loss, but margin capture is limited.
• Short ACA-sensitive health-insurance suppliers and brokers on any rally into enrollment season; the cleanest catalyst window is the next 1-2 quarters when 2026 enrollment assumptions get reset.
• Use options rather than outright shorts in the provider complex: bad-debt concerns can be slow to hit reported earnings, so long-dated puts on vulnerable names offer better convexity than cash equity shorts.